Biogen | BIIB - EPS Earnings Per Share


Biogen reported $1.99 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 3.06 3.02 May/06
FY2025Q4 Dec/2025 1.99 1.74 3.44 Feb/06
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30
FY2025Q2 Jun/2025 5.47 4.08 5.28 Jul/31
FY2025Q1 Mar/2025 3.02 3.96 3.67 May/01




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.53 1.38 Dec/2025
Sanofi EUR -0.67 3.62 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025